|
24 Jan 2025
|
Quarterly Results |
- |
|
29 Oct 2024
|
Quarterly Results |
- |
|
05 Aug 2024
|
Quarterly Results |
- |
|
06 May 2024
|
Audited Results |
- |
|
30 Jan 2024
|
Quarterly Results |
- |
|
04 Nov 2023
|
Quarterly Results |
- |
|
08 Aug 2023
|
Quarterly Results |
- |
|
09 May 2023
|
Audited Results |
- |
|
02 Feb 2023
|
Quarterly Results |
- |
|
10 Nov 2022
|
Quarterly Results |
- |
|
12 Oct 2022
|
Right issue of equity shares |
- |
|
26 Jul 2022
|
Quarterly Results |
- |
|
24 Jun 2022
|
Rights issue |
Inter alia, to consider matters related to raising of funds through issue of equity shares of the Company on rights basis to the existing equity shareholders of the Company. |
|
07 May 2022
|
Audited Results |
- |
|
31 Jan 2022
|
Quarterly Results |
- |
|
25 Oct 2021
|
Quarterly Results |
- |
|
09 Aug 2021
|
Quarterly Results |
- |
|
04 May 2021
|
Audited Results |
- |
|
28 Jan 2021
|
Quarterly Results |
- |
|
27 Oct 2020
|
Quarterly Results |
- |
|
11 Aug 2020
|
Quarterly Results & ESOP |
- |
|
05 Jun 2020
|
Audited Results |
- |
|
13 Feb 2020
|
Quarterly Results |
- |
|
14 Nov 2019
|
Quarterly Results |
- |
|
14 Aug 2019
|
Quarterly Results |
- |
|
25 May 2019
|
Audited Results |
- |
|
09 Mar 2019
|
Others |
To consider and approve the investments in new overseas subsidiary and other matters, if any. |
|
05 Feb 2019
|
Quarterly Results & Interim Dividend |
- |
|
14 Nov 2018
|
Quarterly Results |
- |
|
14 Aug 2018
|
Unaudited Financial Results |
- |
|
15 May 2018
|
Audited Results |
- |
|
30 Jan 2018
|
Quarterly Results & Interim Dividend |
- |
|
11 Nov 2017
|
Quarterly Results |
- |
|
14 Aug 2017
|
Quarterly Results |
- |
|
13 May 2017
|
Audited Results |
- |
|
01 Feb 2017
|
Quarterly Results & Interim Dividend |
- |
|
24 Nov 2016
|
Quarterly Results |
- |
|
10 Aug 2016
|
Quarterly Results |
- |
|
27 May 2016
|
Audited Results |
- |
|
05 Mar 2016
|
Interim Dividend |
- |
|
12 Feb 2016
|
Quarterly Results |
- |
|
10 Nov 2015
|
Quarterly Results |
- |
|
14 Aug 2015
|
Quarterly Results |
Interalia, has authorized to create an overseas subsidiary with an initial investment of US$ 25 Mn for clinical development and commercialization of Suven pipeline and in-licensed molecules. |
|
26 May 2015
|
Audited Results & Dividend |
- |
|
10 Feb 2015
|
Quarterly Results |
Mr. P. Subba Rao, the GM (Finance & Costing) has been appointed as Chief Financial Officer (CFO) of the Company by the Board. |
|
14 Nov 2014
|
Quarterly Results |
- |
|
22 Sep 2014
|
Alteration of AoA of the Company |
1. To consider alteration of Articles of Association of the Company. 2. To consider fund raising programmes through various means. |
|
12 Aug 2014
|
Quarterly Results |
- |
|
22 May 2014
|
Audited Results & Dividend |
- |
|
04 Feb 2014
|
Quarterly Results |
- |
|
11 Nov 2013
|
Quarterly Results |
- |
|
13 Aug 2013
|
Quarterly Results |
- |
|
14 May 2013
|
Audited Results & Dividend |
- |
|
12 Feb 2013
|
Quarterly Results |
- |
|
14 Nov 2012
|
Quarterly Results |
- |
|
14 Aug 2012
|
Audited, Quarterly Results & Dividend |
For year ended 31-03-2012 & for quarter ended 30-6-2012. |
|
04 May 2012
|
Quarterly Results |
- |
|
31 Jan 2012
|
Quarterly Results & Others |
The Board has given its consent for the Amalgamation of the said Wholly owned Subsidiary - Suven Nishtaa Pharma Private Limited with the holding Company - Suven Life Sciences Limited. |
|
01 Nov 2011
|
Quarterly Results |
- |
|
13 Aug 2011
|
Quarterly Results |
- |
|
30 May 2011
|
Audited Results & Dividend |
- |
|
31 Jan 2011
|
Quarterly Results |
- |
|
27 Oct 2010
|
Quarterly Results |
- |
|
27 Jul 2010
|
Quarterly Results |
- |
|
30 Apr 2010
|
Audited Results & Dividend |
- |
|
27 Jan 2010
|
Quarterly Results |
- |
|
31 Oct 2009
|
Quarterly Results |
- |
|
22 Sep 2009
|
To approve the Cost Accounts |
inter alia, to consider and approve Cost Accounts of the Company for the year 2008-09. |
|
28 Jul 2009
|
Audited, Qtr. Results, Dividend & Others |
To raise funds to the tune of 50 Million USD or its equivalent of any other Foreign/ Indian currencies through issue of Equity Shares / GDRs / ADRs / FCCBs and /or such other securities. |
|
29 Apr 2009
|
Quarterly Results |
- |
|
19 Jan 2009
|
Quarterly Results |
- |
|
31 Oct 2008
|
Quarterly Results |
- |
|
18 Sep 2008
|
To consider & approve Cost Accounts |
To consider and approve Cost Accounts of the Company for the year 2007-2008. |
|
25 Jul 2008
|
Audited, Quarterly Results & Dividend |
To announce Book Closure for the purpose of AGM and distribution of Dividend. |
|
26 Apr 2008
|
Quarterly Results |
- |
|
28 Jan 2008
|
Quarterly Results |
- |
|
30 Oct 2007
|
Quarterly Results |
- |
|
27 Sep 2007
|
To approve the Cost Accounts |
To consider and approve the Cost Accounts of the Company for the year 2006-2007. |
|
31 Jul 2007
|
Audited Results, Dividend & Qtr Results |
- |
|
26 Apr 2007
|
Quarterly Results |
- |
|
29 Jan 2007
|
Quarterly, Bonus Issue & Stock Split |
- |
|
06 Dec 2006
|
To consider and issue and allot |
37,25,000 equity shares of Rs 2/- each to the shareholders of Asian Clinical Trials Ltd (Transferor Company) |
|
30 Oct 2006
|
Quarterly Results |
- |
|
30 Sep 2006
|
To consider the Cost Accounts |
To consider the Cost Accounts of the Company for the year 2005-06. |
|
31 Jul 2006
|
Accounts, Dividend & Qtr. Results |
for the year ended 31st March, 2006. |
|
29 Apr 2006
|
Quarterly Results |
- |
|
06 Mar 2006
|
Scheme of Arrangement |
To approve the draft Scheme of merger of Asian Clinical Trials Ltd with the Company. (Revised) |
|
28 Jan 2006
|
Quarterly Results |
- |
|
29 Oct 2005
|
Quarterly Results |
- |
|
30 Jul 2005
|
Accounts, Dividend & Quarterly Results |
- |
|
28 Apr 2005
|
Quarterly Results |
- |
|
15 Jan 2005
|
Quarterly Results |
- |
|
28 Oct 2004
|
Quarterly Results |
- |
|
17 Sep 2004
|
General |
- |
|
30 Jul 2004
|
Accounts, Dividend & Quarterly Results |
- |
|
26 Apr 2004
|
Quarterly Results |
- |
|
31 Jan 2004
|
Quarterly Results |
- |
|
05 Jan 2004
|
Others |
To consider & announce the record date for the purpose of of subdivision of Equity shares into Face value of Rs. 2/- each. |
|
04 Dec 2003
|
Stock Split & Others |
Merger of subsidiary - Suven Synthetics Ltd. into Suven Life Sciences Ltd. & Increase of investment limits of FII's |
|
21 Oct 2003
|
Quarterly Results |
- |